Cargando…
Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia
While cancer treatment has improved dramatically, it has also encountered many critical challenges, such as disease recurrence, metastasis, and drug resistance, making new drugs with novel mechanisms an urgent clinical need. The term “drug repositioning,” also known as old drugs for new uses, has em...
Autores principales: | Zhou, Daipeng, Wang, Lei, Cui, Qingbin, Iftikhar, Ryma, Xia, Yanfei, Xu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379838/ https://www.ncbi.nlm.nih.gov/pubmed/32766241 http://dx.doi.org/10.3389/fcell.2020.00565 |
Ejemplares similares
-
Time-Course Transcriptome Analysis for Drug Repositioning in Fusobacterium nucleatum-Infected Human Gingival Fibroblasts
por: Kang, Wenyan, et al.
Publicado: (2019) -
Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs
por: Fan, Hua-yang, et al.
Publicado: (2021) -
Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
por: Liao, Gaoming, et al.
Publicado: (2022) -
Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata
por: Ulm, J. Wes, et al.
Publicado: (2023) -
Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs
por: Baiken, Yeldar, et al.
Publicado: (2021)